Haemonetics Corp. buy Barrington Research
Start price
13.02.24
/
50%
€66.00
Target price
13.02.25
€97.90
Performance (%)
28.03%
Price
26.04.24
€84.50
Summary
This prediction is currently active. The prediction currently has a performance of 28.03%. This prediction currently runs until 13.02.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Haemonetics Corp. | 11.921% | 11.921% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat